The landscape of HIV prevention has undergone a profound transformation with significant advancements in medical interventions and a deeper understanding of how the virus spreads. These developments ...

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. The twice-yearly shot was 100% effective in preventing HIV infections in a study of women, and ...

Jared Baeten, MD, PhD, discusses the significance of the PURPOSE 1 trial results, which found that lenacapavir for pre-exposure prophylaxis resulted in no new infections of HIV. How significant is it ...

PITTSBURGH – December 6, 2023 – A fast-dissolving vaginal insert that women would use at or around the time of sex as an “on-demand” HIV prevention method is being evaluated in a new early phase study ...

The number of new HIV infections has fallen over the years – it declined by 39% from 2010 to 2023. But HIV’s devastating impact on global health persists. In 2023, 1.3 million people acquired HIV – ...

A groundbreaking medical advancement could reshape the future of HIV prevention. In a landmark clinical trial, a twice-yearly injection of lenacapavir demonstrated an astonishing 96% effectiveness in ...

Despite the major advancements in HIV management, the global burden of HIV remains high with women continuing to bear the brunt of the epidemic. According to UNAIDS, globally, women accounted for 46 ...

Rural Appalachian women face increased HIV risk due to opioid and polysubstance use, necessitating novel intervention delivery methods. Facebook was used as a platform for delivering HIV prevention ...

"Pre-exposure prophylaxis (PrEP) is the most important concept in the [HIV] prevention field today," Robert Grant told the Infectious Disease Society of America at their annual meeting in San Diego.

HIV incidence rates remain higher than the level of epidemic control in many African countries. Despite the availability of cost-free, highly-effective HIV prevention interventions, such as ...

The CDC estimates 2.2 million Americans could benefit from HIV prevention drugs, but just over a quarter of that group have ...